<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00645801</url>
  </required_header>
  <id_info>
    <org_study_id>07-024L</org_study_id>
    <nct_id>NCT00645801</nct_id>
  </id_info>
  <brief_title>Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation</brief_title>
  <official_title>Amitiza® (Lubiprostone) Plus GoLYTELY® (Polyethylene Glycol-electrolyte Solution) vs. Placebo Plus GoLYTELY® (Polyethylene Glycol-electrolyte Solution) for Outpatient Colonoscopy Preparation: A Randomized, Double-blind, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Takeda Pharmaceuticals North America, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to compare the effectiveness and tolerance of Amitiza®
      (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo and
      GoLYTELY ® (polyethylene glycol-electrolyte solution) as a bowel cleansing preparation for
      colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amitiza® (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo plus GoLYTELY® (polyethylene glycol-electrolyte solution) for outpatient colonoscopy preparation: A randomized, double-blind, placebo-controlled trial.</measure>
    <time_frame>3 years</time_frame>
    <description>The primary objective of this study is to compare the efficacy and tolerability of Amitiza plus GoLytely to the efficacy and tolerability of a placebo plus GoLytely.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Amitiza® (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo plus GoLYTELY® (polyethylene glycol-electrolyte solution) for outpatient colonoscopy preparation: A randomized, double-blind, placebo-controlled trial.</measure>
    <time_frame>3 years</time_frame>
    <description>The secondary objective is to evaluate the effectiveness of a decreased volume of GoLytely in patient taking active drug compared with placebo.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">158</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive both Amitiza and GoLYTELY</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive Amitiza Placebo plus GoLYTELY</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lubiprostone (Amitiza)</intervention_name>
    <description>24 mcg administered 4 times over the two days before the colonoscopy. 96 mcg total</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Amitiza</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Amitiza Placebo</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is at least 18 years old

          -  Subject is in good health

          -  Subject is undergoing a screening colonoscopy

          -  Subject has a spontaneous bowel movement at least every 48 hours

        Exclusion Criteria:

          -  Subject has renal insufficiency demonstrated by serum creatinine &gt; 1.4mg/dL

          -  Subject has Type 1 diabetes

          -  Subject has past or present diagnosis of Congestive Heart Failure

          -  Subject has past or present diagnosis of inflammatory bowel disease

          -  Subject had previous colon resection

          -  Subject has a preexisting electrolyte abnormality

          -  Subject has more than 3 spontaneous bowel movements daily
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ann L Silverman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>War Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48377</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2008</study_first_submitted>
  <study_first_submitted_qc>March 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2008</study_first_posted>
  <last_update_submitted>September 4, 2012</last_update_submitted>
  <last_update_submitted_qc>September 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>War Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Ann L. Silverman</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Routine screening colonoscopy</keyword>
  <keyword>Colonoscopy Preparation</keyword>
  <keyword>Amitiza</keyword>
  <keyword>GoLYTELY</keyword>
  <keyword>Pegylated Electrolytes</keyword>
  <keyword>Preparation Solution</keyword>
  <keyword>Colonoscopy Solution</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Lubiprostone</mesh_term>
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

